Getinge is in the business of infection control to health systems and also makes products to prevent contamination for life science companies.

Last year, the Swedish company's share price dropped 19%, to 177.80 Swedish Krona ($20.75) from 220 Swedish Krona ($33.77) at the end of 2013. As a result, $2.18 billion was wiped out from its market cap.